Vivos (RDGL) EBITDA Margin (2010 - 2025)

Vivos' (RDGL) quarterly EBITDA Margin came in at 4426.79% in Q4 2025, up 882246.0% year-on-year from N/an in Q4 2024, and up 84.34% quarter-over-quarter from 28260.94% in Q3 2025.

Vivos (RDGL) EBITDA Margin (2010 - 2025) Analysis & Trends

Vivos has disclosed EBITDA Margin across 16 years of filings, most recently posting 4426.79% for Q4 2025.

  • EBITDA Margin for Q4 2025 came in at 4426.79%, up 882246.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 4628.68% (up 467435.0% YoY), and the FY2025 annual result was 4628.68%, up 467435.0% from the prior year.
  • EBITDA Margin came in at 4426.79% for Q4 2025 at Vivos, up from 28260.94% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 1307.07% in Q3 2021 to a low of 28260.94% in Q3 2025.
  • The 5-year median for EBITDA Margin is 6625.15% (2022), against an average of 9058.02%.
  • Across the five-year window, EBITDA Margin soared 1019881 bps in 2024 and sank 1139804 bps in 2025, its largest moves.
  • Vivos' EBITDA Margin stood at 1307.07% in 2021, then tumbled by 731 bps to 10857.87% in 2022, then climbed by 10 bps to 9823.33% in 2023, then slumped by 35 bps to 13249.25% in 2024, then jumped by 67 bps to 4426.79% in 2025.
  • The last three EBITDA Margin figures came in at 4426.79% (Q4 2025), 28260.94% (Q3 2025), and 4498.48% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 12.05%
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 15.55%
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 16.24%
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 28.97%
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 10.04%
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 21.42%
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 19.94%
10 Vivos - - -3,105.00 -4,426.79%

Historic Data

Download Data
DateValue
Dec 31, 2025 -4,426.79%
Sep 30, 2025 -28,260.94%
Jun 30, 2025 -4,498.48%
Mar 31, 2025 -3,228.40%
Dec 31, 2024 -13,249.25%
Sep 30, 2024 -16,862.90%
Jun 30, 2024 -3,868.96%
Mar 31, 2024 -12,825.09%
Sep 30, 2023 -9,823.33%
Jun 30, 2023 -14,067.77%
Mar 31, 2023 -4,138.63%
Dec 31, 2022 -10,857.87%
Sep 30, 2022 -4,262.54%
Jun 30, 2022 -7,500.36%
Mar 31, 2022 -5,749.95%
Sep 30, 2021 -1,307.07%
Sep 30, 2020 -1,834.86%
Dec 31, 2019 -21,636.87%
Sep 30, 2019 -7,590.09%
Mar 31, 2018 -1,630.52%